Search research articles
Contact Us
Filters
Showing results (311-320 of 451) with videos related to
Page
of 46
Sort By:
The American Journal of Gastroenterology
|
August 10, 2005
A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use
Angel Lanas, Maria Angeles Perez-Aisa, Faust Feu, et al.
Plos One
|
November 15, 2022
Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-α/γ agonist aleglitazar
Esmée J Grobbee, Vivian D de Jong, Ilse C Schrieks, et al.
The American Journal of Gastroenterology
|
February 4, 2006
Third-line rescue therapy with levofloxacin after two H. pylori treatment failures
Javier P Gisbert, Manuel Castro-Fernández, Fernando Bermejo, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis
|
May 29, 2014
The postprandial situation as a pro-inflammatory condition
Marijke A de Vries, Boudewijn Klop, Silvia A Eskes, et al.
European Journal of Clinical Investigation
|
April 12, 2019
The effect of sex and menopause on carotid intima-media thickness and pulse wave velocity in morbid obesity
Stefanie R van Mil, L Ulas Biter, Gert Jan M van de Geijn, et al.
European Journal of Clinical Investigation
|
January 10, 2012
Exploring the value of apoB48 as a marker for atherosclerosis in clinical practice
Arash Alipour, Pedro Valdivielso, Jan Willem F Elte, et al.
Obesity Surgery
|
March 15, 2018
Contribution of Type 2 Diabetes Mellitus to Subclinical Atherosclerosis in Subjects with Morbid Obesity
Stefanie R van Mil, L Ulas Biter, Gert-Jan M van de Geijn, et al.
Obesity Surgery
|
April 22, 2021
Cardiac Function Normalizes 1 Year After Bariatric Surgery in Half of the Obesity Patients with Subclinical Cardiac Dysfunction
Sanne M Snelder, Yaar Aga, Lotte E de Groot-de Laat, et al.
BMC Gastroenterology
|
July 27, 2007
Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection
José M Navarro-Jarabo, Nuria Fernández, Francisca L Sousa, et al.
Gut
|
May 14, 2013
Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice
Adrian G McNicholl, Alicia C Marin, Javier Molina-Infante, et al.
Page
of 46
Search research articles
Search
Showing results (311-320 of 451) with videos related to
Sort By:
Page
of 46
The American Journal of Gastroenterology
|
August 10, 2005
A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use
Angel Lanas, Maria Angeles Perez-Aisa, Faust Feu, et al.
Plos One
|
November 15, 2022
Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-α/γ agonist aleglitazar
Esmée J Grobbee, Vivian D de Jong, Ilse C Schrieks, et al.
The American Journal of Gastroenterology
|
February 4, 2006
Third-line rescue therapy with levofloxacin after two H. pylori treatment failures
Javier P Gisbert, Manuel Castro-Fernández, Fernando Bermejo, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis
|
May 29, 2014
The postprandial situation as a pro-inflammatory condition
Marijke A de Vries, Boudewijn Klop, Silvia A Eskes, et al.
European Journal of Clinical Investigation
|
April 12, 2019
The effect of sex and menopause on carotid intima-media thickness and pulse wave velocity in morbid obesity
Stefanie R van Mil, L Ulas Biter, Gert Jan M van de Geijn, et al.
European Journal of Clinical Investigation
|
January 10, 2012
Exploring the value of apoB48 as a marker for atherosclerosis in clinical practice
Arash Alipour, Pedro Valdivielso, Jan Willem F Elte, et al.
Obesity Surgery
|
March 15, 2018
Contribution of Type 2 Diabetes Mellitus to Subclinical Atherosclerosis in Subjects with Morbid Obesity
Stefanie R van Mil, L Ulas Biter, Gert-Jan M van de Geijn, et al.
Obesity Surgery
|
April 22, 2021
Cardiac Function Normalizes 1 Year After Bariatric Surgery in Half of the Obesity Patients with Subclinical Cardiac Dysfunction
Sanne M Snelder, Yaar Aga, Lotte E de Groot-de Laat, et al.
BMC Gastroenterology
|
July 27, 2007
Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection
José M Navarro-Jarabo, Nuria Fernández, Francisca L Sousa, et al.
Gut
|
May 14, 2013
Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice
Adrian G McNicholl, Alicia C Marin, Javier Molina-Infante, et al.
Page
of 46